BTCC
/
BTCC Square
/
Global Cryptocurrency
/
AI Identifies Key Alzheimer’s Gene, Opening Door to New Treatments
AI Identifies Key Alzheimer’s Gene, Opening Door to New Treatments
14
1
Researchers at the University of California, San Diego have Leveraged artificial intelligence to pinpoint PHGDH as a causative gene in Alzheimer’s disease. The breakthrough, published in Cell, redefines previous assumptions about the gene’s role—shifting from biomarker to mechanistic driver of neurodegeneration.
The discovery reveals how PHGDH disrupts transcriptional regulation in the brain, leading to spontaneous Alzheimer’s pathology. This paradigm shift enables targeted therapeutic development, with Nvidia highlighting the potential for AI-driven drug discovery pipelines to accelerate treatment options.
By:
Previous
NVIDIA Advances AI-Driven Digital Twins for Enhanced CFD Simulations
Next
Nexo’s Private Client Club Unveils Exclusive Benefits for Crypto Elite with $100K Minimum
